Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients

OBJECTIVE: To explore the validation of a disease-free survival (DFS) model for predicting disease progression based on the combination of ubiquitin-conjugating enzyme E2 C (UBE2C) levels and clinical indicators in breast cancer patients. METHODS: We enrolled 121 patients with breast cancer, collect...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jun, Yan, Huanhuan, Yang, Congying, Lin, Haiyue, Li, Fan, Zhou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149777/
https://www.ncbi.nlm.nih.gov/pubmed/37139241
http://dx.doi.org/10.2147/BCTT.S402109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149777/
https://www.ncbi.nlm.nih.gov/pubmed/37139241
http://dx.doi.org/10.2147/BCTT.S402109

Ejemplares similares